Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study
- PMID: 33131493
- PMCID: PMC7604931
- DOI: 10.1186/s12887-020-02404-2
Risk factors associated with renal crescentic formation in pediatric Henoch-Schönlein purpura nephritis: a retrospective cohort study
Abstract
Background: The long-term prognosis of Henoch-Schönlein purpura (HSP) depends on the severity of renal involvement, and crescent formation is considered an important risk factor for poor prognosis of Henoch-Schönlein purpura nephritis (HSPN). The objective of this study was to evaluate factors affecting crescent formation in children with HSPN.
Methods: Demographic factors, clinical characteristics, and laboratory data of children with HSPN with or without crescents were retrospectively analyzed. Univariate and multivariate logistic regression analyses were used to determine the risk factors of crescent formation in HSPN.
Results: A total of 191 children with HSPN were enrolled in the study. There were 107 (56%) males and 84 (44%) females, with a median age of 7 years (range: 2 years-15 years). International Study of Kidney Disease in Children (ISKDC) grading was used to divide subjects into two groups: those without glomerular crescent formation (ISKDC grades I-II, n = 146 cases) and those with glomerular crescent formation (ISKDC grades III-V, n = 45 cases). Logistic regression analysis showed that higher urinary white blood cell (WBC) count (OR = 3.300; 95% CI, 1.119-9.739; P = 0.0306) and higher urinary microalbumin/creatinine ratio (ACR) (OR = 25.053; 95% CI, 1.354-463.708; P = 0.0305) were independent risk factors for the formation of crescents in HSPN. The area under the receiver operating characteristic curve of urinary WBC and ACR were 0.753 and 0.698 respectively, with the Hosmer and Lemeshow goodness-of-fit test (P = 0.0669, P > 0.05).
Conclusion: These results suggest that higher urinary WBC count and ACR should be strictly monitored for children with HSPN. Adequate clinical intervention for these risk factors may limit or prevent renal crescent formation.
Keywords: Crescent formation; HSPN; Henoch-Schönlein purpura nephritis; Risk factors.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Ultrasound-Based Radiomics for the Classification of Henoch-Schönlein Purpura Nephritis in Children.Ultrason Imaging. 2024 Mar;46(2):110-120. doi: 10.1177/01617346231220000. Epub 2023 Dec 22. Ultrason Imaging. 2024. PMID: 38140769 Clinical Trial.
-
Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?Pediatr Rheumatol Online J. 2019 Feb 28;17(1):10. doi: 10.1186/s12969-019-0311-z. Pediatr Rheumatol Online J. 2019. PMID: 30819179 Free PMC article. Review.
-
Exploring potential predictors of Henoch-Schönlein purpura nephritis: a pilot investigation on urinary metabolites.Eur J Pediatr. 2024 Jul;183(7):3117-3128. doi: 10.1007/s00431-024-05573-9. Epub 2024 Apr 26. Eur J Pediatr. 2024. PMID: 38668796
-
Value of the modified semiquantitative classification in predicting outcomes in children with Henoch-Schönlein purpura nephritis.Nephrology (Carlton). 2023 Sep;28(9):495-505. doi: 10.1111/nep.14193. Epub 2023 Jun 15. Nephrology (Carlton). 2023. PMID: 37323118
-
Predictability of the Oxford classification of IgA nephropathy in Henoch-Schonlein purpura nephritis.Int Urol Nephrol. 2022 Jan;54(1):99-109. doi: 10.1007/s11255-021-02861-3. Epub 2021 Apr 27. Int Urol Nephrol. 2022. PMID: 33905044
Cited by
-
Effects of disease severity-based nursing intervention on immune function and IFN-γ, IL-6, and TNF-α for children with IgA vasculitis nephritis.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 2. doi: 10.1007/s00210-025-04325-2. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40455234
-
[Efficacy and safety of mycophenolate mofetil versus cyclophosphamide in the treatment of Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria in children: a prospective randomized controlled trial].Zhongguo Dang Dai Er Ke Za Zhi. 2021 Apr;23(4):338-342. doi: 10.7499/j.issn.1008-8830.2012145. Zhongguo Dang Dai Er Ke Za Zhi. 2021. PMID: 33840404 Free PMC article. Clinical Trial. Chinese.
-
[Clinical and pathological features of children with immunoglobulin A vasculitis with nephritis accompanied by different proportions of crescent formation].Zhongguo Dang Dai Er Ke Za Zhi. 2024 Dec 15;26(12):1329-1334. doi: 10.7499/j.issn.1008-8830.2407060. Zhongguo Dang Dai Er Ke Za Zhi. 2024. PMID: 39725397 Free PMC article. Chinese.
-
Risk Factors of Histopathological Crescent Formation in Pediatric IgA Vasculitis Nephritis.Medicina (Kaunas). 2025 Aug 6;61(8):1421. doi: 10.3390/medicina61081421. Medicina (Kaunas). 2025. PMID: 40870466 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources